Skip to main content

Table 1 Baseline characteristics of the 18 patients with CEP at diagnosis

From: Significance of fractional exhaled nitric oxide in chronic eosinophilic pneumonia: a retrospective cohort study

Variable Value* Number reported/tested
Age (years) 56 (41–68) 18
Disease duration (months) 19.1 (9.9–28.7) 18
Gender   18
  Female 8 (44.4)  
  Male 10 (55.6)  
Smoking status   18
  Current smoker 1 (5.6)  
  Ex-smoker 4 (22.2)  
  Pack-year history 25 (20–40)  
Symptoms or signs   18
  Cough 15 (83.3)  
  Sputum 13 (72.2)  
  Dyspnea 5 (27.8)  
  Fever 2 (11.1)  
  Wheezing 4 (22.2)  
  Crackle 3 (16.7)  
History of tuberculosis 1 (5.6) 18
Laboratory findings   
  White blood count (cells/μL) 8060 (7470–9660) 18
  Peripheral eosinophil percentage (%) 21.2 (11.6–42.3) 18
  Peripheral eosinophil count (cells/μL) 1543 (771–4034) 18
  Eosinophil percentage in BAL fluid (%) 47 (15–65) 7
  C-reactive protein (mg/dL) 1.5 (0.30–3.27) 15
  Aspartate aminotransferase (IU/L) 21 (17–24) 17
  Alanine aminotransferase (IU/L) 17 (12–24) 17
  Blood urea nitrogen (mg/dL) 10 (8–11) 17
  Creatinine (mg/dL) 0.84 (0.66–0.98) 17
Spirometric results   
  Forced expiratory volume in 1 s/forced vital capacity ratio 76.0 (62–82) 15
  % predicted forced expiratory volume in 1 s 87.0 (67–100) 15
  % predicted forced vital capacity 86.0 (72–97) 15
  1. *Data represent median (IQR) or number of patients (%).